BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32647264)

  • 1. Impaired iloprost-induced platelet inhibition and phosphoproteome changes in patients with confirmed pseudohypoparathyroidism type Ia, linked to genetic mutations in GNAS.
    Swieringa F; Solari FA; Pagel O; Beck F; Huang J; Feijge MAH; Jurk K; Körver-Keularts IMLW; Mattheij NJA; Faber J; Pohlenz J; Russo A; Stumpel CTRM; Schrander DE; Zieger B; van der Meijden PEJ; Zahedi RP; Sickmann A; Heemskerk JWM
    Sci Rep; 2020 Jul; 10(1):11389. PubMed ID: 32647264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gsα activity is reduced in erythrocyte membranes of patients with psedohypoparathyroidism due to epigenetic alterations at the GNAS locus.
    Zazo C; Thiele S; Martín C; Fernandez-Rebollo E; Martinez-Indart L; Werner R; Garin I; ; Hiort O; Perez de Nanclares G
    J Bone Miner Res; 2011 Aug; 26(8):1864-70. PubMed ID: 21351142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients.
    Mantovani G; de Sanctis L; Barbieri AM; Elli FM; Bollati V; Vaira V; Labarile P; Bondioni S; Peverelli E; Lania AG; Beck-Peccoz P; Spada A
    J Clin Endocrinol Metab; 2010 Feb; 95(2):651-8. PubMed ID: 20061437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy.
    de Nanclares GP; Fernández-Rebollo E; Santin I; García-Cuartero B; Gaztambide S; Menéndez E; Morales MJ; Pombo M; Bilbao JR; Barros F; Zazo N; Ahrens W; Jüppner H; Hiort O; Castaño L; Bastepe M
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2370-3. PubMed ID: 17405843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type Ic defines a new subgroup of pseudohypoparathyroidism affecting selectively Gsα-receptor interaction.
    Thiele S; de Sanctis L; Werner R; Grötzinger J; Aydin C; Jüppner H; Bastepe M; Hiort O
    Hum Mutat; 2011 Jun; 32(6):653-60. PubMed ID: 21488135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations.
    Elli FM; de Sanctis L; Bollati V; Tarantini L; Filopanti M; Barbieri AM; Peverelli E; Beck-Peccoz P; Spada A; Mantovani G
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E508-17. PubMed ID: 24423294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical features of two cases of pseudohypoparathyroidism (ia and ib) and molecular analysis of GNAS].
    Domínguez García A; Castaño González LA; Pérez-Nanclares G; Quinteiro González S; Caballero Fernández E
    An Pediatr (Barc); 2013 Nov; 79(5):319-24. PubMed ID: 23623851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up Findings in a Turkish Girl with Pseudohypoparathyroidism Type Ia Caused by a Novel Heterozygous Mutation in the GNAS Gene.
    Şahin S; Hiort O; Thiele S; Evliyaoğlu O; Tüysüz B
    J Clin Res Pediatr Endocrinol; 2017 Mar; 9(1):74-79. PubMed ID: 27425121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective deficiency of Gsalpha and the possible role of alternative gene products of GNAS in Albright hereditary osteodystrophy and pseudohypoparathyroidism type Ia.
    Thiele S; Werner R; Ahrens W; Hübner A; Hinkel KG; Höppner W; Igl B; Hiort O
    Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):127-32. PubMed ID: 19658058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and epigenetic alterations in the GNAS locus and clinical consequences in Pseudohypoparathyroidism: Italian common healthcare pathways adoption.
    de Sanctis L; Giachero F; Mantovani G; Weber G; Salerno M; Baroncelli GI; Elli MF; Matarazzo P; Wasniewska M; Mazzanti L; Scirè G; Tessaris D;
    Ital J Pediatr; 2016 Nov; 42(1):101. PubMed ID: 27871293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudohypoparathyroidism: complex disease variants with unfortunate names.
    Jüppner H
    J Mol Endocrinol; 2024 Jan; 72(1):. PubMed ID: 37965945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Definition of Pseudohypoparathyroidism Variants.
    Jüppner H
    J Clin Endocrinol Metab; 2021 May; 106(6):1541-1552. PubMed ID: 33529330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudohypoparathyroidism type Ia and pseudo-pseudohypoparathyroidism: the growing spectrum of GNAS inactivating mutations.
    Elli FM; deSanctis L; Ceoloni B; Barbieri AM; Bordogna P; Beck-Peccoz P; Spada A; Mantovani G
    Hum Mutat; 2013 Mar; 34(3):411-6. PubMed ID: 23281139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound heterozygous mutations in the GNAS gene of a boy with morbid obesity, thyroid-stimulating hormone resistance, pseudohypoparathyroidism, and a prothrombotic state.
    Freson K; Izzi B; Jaeken J; Van Helvoirt M; Thys C; Wittevrongel C; de Zegher F; Van Geet C
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4844-9. PubMed ID: 18796523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GNAS locus and pseudohypoparathyroidism.
    Bastepe M
    Adv Exp Med Biol; 2008; 626():27-40. PubMed ID: 18372789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of two different pseudohypoparathyroidism subtypes (Ia and Ib) in the same kindred with independent Gs{alpha} coding mutations and GNAS imprinting defects.
    Lecumberri B; Fernández-Rebollo E; Sentchordi L; Saavedra P; Bernal-Chico A; Pallardo LF; Bustos JM; Castaño L; de Santiago M; Hiort O; Pérez de Nanclares G; Bastepe M
    J Med Genet; 2010 Apr; 47(4):276-80. PubMed ID: 19858129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel GNAS mutation in a case of pseudohypoparathyroidism type 1A with normocalcemia.
    Long XD; Xiong J; Mo ZH; Dong CS; Jin P
    BMC Med Genet; 2018 Jul; 19(1):132. PubMed ID: 30060753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GNAS locus and pseudohypoparathyroidism.
    Bastepe M; Jüppner H
    Horm Res; 2005; 63(2):65-74. PubMed ID: 15711092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of GNAS imprinting defects and deletions of chromosome 2 in two patients: clues explaining phenotypic heterogeneity in pseudohypoparathyroidism type 1B/iPPSD3.
    Elli FM; deSanctis L; Maffini MA; Bordogna P; Tessaris D; Pirelli A; Arosio M; Linglart A; Mantovani G
    Clin Epigenetics; 2019 Jan; 11(1):3. PubMed ID: 30616679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Multiple Families With Single Individuals Affected by Pseudohypoparathyroidism Type Ib (PHP1B) Reveals Only One Novel Maternally Inherited GNAS Deletion.
    Takatani R; Molinaro A; Grigelioniene G; Tafaj O; Watanabe T; Reyes M; Sharma A; Singhal V; Raymond FL; Linglart A; Jüppner H
    J Bone Miner Res; 2016 Apr; 31(4):796-805. PubMed ID: 26479409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.